Ignite Creation Date:
2025-12-24 @ 6:38 PM
Ignite Modification Date:
2026-01-05 @ 6:35 PM
Study NCT ID:
NCT05179057
Status:
TERMINATED
Last Update Posted:
2024-05-08
First Post:
2021-12-17
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Posoleucel (ALVR105) for the Treatment of Adenovirus Infection in Pediatric and Adult Participants Receiving Standard of Care Following Allogeneic Hematopoietic Cell Transplantation
Sponsor:
AlloVir
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-04-26
Start Date Type:
ACTUAL
Primary Completion Date:
2024-01-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-01-31
Completion Date Type:
ACTUAL
First Submit Date:
2021-12-17
First Submit QC Date:
None
Study First Post Date:
2022-01-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-04-15
Results First Submit QC Date:
None
Results First Post Date:
2024-05-08
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-04-15
Last Update Post Date:
2024-05-08
Last Update Post Date Type:
ACTUAL